Literature DB >> 17889480

Characterization of Trypanosoma cruzi isolated from humans, vectors, and animal reservoirs following an outbreak of acute human Chagas disease in Santa Catarina State, Brazil.

Mário Steindel1, Letícia Kramer Pacheco, Daniele Scholl, Marcos Soares, Milene Hoehr de Moraes, Iriane Eger, Cecília Kosmann, Thais Cristine Marques Sincero, Patrícia Hermes Stoco, Silvane Maria Fonseca Murta, Carlos José de Carvalho-Pinto, Edmundo Carlos Grisard.   

Abstract

During March 2005, 24 cases of acute human Chagas disease were detected in Santa Catarina State, southern Brazil, all of them related to the ingestion of Trypanosoma cruzi-contaminated sugar cane juice. Following field studies allowed the isolation of 13 T. cruzi strains from humans, opossums (Didelphis aurita and Didelphis albiventris), and vectors (Triatoma tibiamaculata). The isolated strains were characterized by multilocus enzyme electrophoresis (MLEE) and analysis of the spliced-leader and 24Salpha rRNA genes. The assays revealed that all strains isolated from humans belong to the TcII group but revealed a TcII variant pattern for the phosphoglucomutase enzyme. Strains isolated from opossums also showed a TcI profile in all analysis, but strains isolated from triatomines revealed a mixed TcI/TcII profile by MLEE. No indication of the presence of Trypanosoma rangeli was observed in any assay. Considering that mixed strains (TcI/TcII) were isolated from triatomines in an area without active vectorial transmission to humans and that all strains isolated from humans belong to the TcII group, our results show that T. cruzi TcI and TcII groups are circulating among reservoirs and vectors in southern Brazil and indicate that selection toward TcII group in humans may occur after ingestion of a mixed (TcI/TcII) T. cruzi population.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17889480     DOI: 10.1016/j.diagmicrobio.2007.07.016

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  44 in total

1.  Clinical aspects of Chagas disease and implications for novel therapies.

Authors:  Cristiane Menezes; Germano Carneiro Costa; Kenneth J Gollob; Walderez O Dutra
Journal:  Drug Dev Res       Date:  2011-09       Impact factor: 4.360

2.  Biological and Molecular Characterization of Trypanosoma cruzi Strains from Four States of Brazil.

Authors:  Aline Rimoldi Ribeiro; Luciana Lima; Larissa Aguiar de Almeida; Joana Monteiro; Cláudia Jassica Gonçalves Moreno; Juliana Damieli Nascimento; Renato Freitas de Araújo; Fernanda Mello; Luciamáre Perinetti Alves Martins; Márcia Aparecida Silva Graminha; Marta Maria Geraldes Teixeira; Marcelo Sousa Silva; Mário Steindel; João Aristeu da Rosa
Journal:  Am J Trop Med Hyg       Date:  2018-01-04       Impact factor: 2.345

Review 3.  Current concepts in immunoregulation and pathology of human Chagas disease.

Authors:  Walderez O Dutra; Kenneth J Gollob
Journal:  Curr Opin Infect Dis       Date:  2008-06       Impact factor: 4.915

4.  Cellular and genetic mechanisms involved in the generation of protective and pathogenic immune responses in human Chagas disease.

Authors:  Walderez Ornelas Dutra; Cristiane Alves Silva Menezes; Fernanda Nobre Amaral Villani; Germano Carneiro da Costa; Alexandre Barcelos Morais da Silveira; Débora d'Avila Reis; Kenneth J Gollob
Journal:  Mem Inst Oswaldo Cruz       Date:  2009-07       Impact factor: 2.743

5.  Croton cajucara crude extract and isolated terpenes: activity on Trypanosoma cruzi.

Authors:  Monica C O Campos; Kelly Salomão; Denise B Castro-Pinto; Leonor L Leon; Helene S Barbosa; Maria Aparecida M Maciel; Solange L de Castro
Journal:  Parasitol Res       Date:  2010-08-03       Impact factor: 2.289

Review 6.  Immunoregulatory networks in human Chagas disease.

Authors:  W O Dutra; C A S Menezes; L M D Magalhães; K J Gollob
Journal:  Parasite Immunol       Date:  2014-08       Impact factor: 2.280

Review 7.  Between a bug and a hard place: Trypanosoma cruzi genetic diversity and the clinical outcomes of Chagas disease.

Authors:  Louisa A Messenger; Michael A Miles; Caryn Bern
Journal:  Expert Rev Anti Infect Ther       Date:  2015-08       Impact factor: 5.091

8.  Chronic Chagas Disease Diagnosis: A Comparative Performance of Commercial Enzyme Immunoassay Tests.

Authors:  Fred Luciano Neves Santos; Wayner Vieira de Souza; Michelle da Silva Barros; Mineo Nakazawa; Marco Aurélio Krieger; Yara de Miranda Gomes
Journal:  Am J Trop Med Hyg       Date:  2016-03-14       Impact factor: 2.345

Review 9.  Regulation of CD8+ T cell responses to infection with parasitic protozoa.

Authors:  Kimberly A Jordan; Christopher A Hunter
Journal:  Exp Parasitol       Date:  2010-05-21       Impact factor: 2.011

10.  Characterising the KMP-11 and HSP-70 recombinant antigens' humoral immune response profile in chagasic patients.

Authors:  Ivonne D Flechas; Adriana Cuellar; Zulma M Cucunubá; Fernando Rosas; Víctor Velasco; Mario Steindel; María del Carmen Thomas; Manuel Carlos López; John Mario González; Concepción Judith Puerta
Journal:  BMC Infect Dis       Date:  2009-11-25       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.